EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

Single‐Nucleus Transcriptomics Uncovers Xaf1‐Driven PANoptosis as a Therapeutic Target in Aminoglycoside‐Induced Hearing Loss

Xinlin Wang, Hairong Xiao, Jiheng Wu, Yanqin Lin, Yiheng Ao, Zixuan Ye, Xin Tan, Fanliang Kong, Xin Chen, Renjie Chai iD, Shasha Zhang iD

Cell Proliferation · 2026

DOI: 10.1111/cpr.70081 ↗

At a glance

Journal article in Cell Proliferation, 2026. Written by Xinlin Wang and 10 co-authors. Institution: Department of Otolaryngology Head and Neck Surgery, Zhongda Hospital, State Key Laboratory of Digital Medical Engineering, Jiangsu Provincial Key Lab…. Major MEDLINE topics: Aminoglycosides, Transcriptome, Hearing Loss, Adaptor Proteins, Signal Transducing. 59 references. The full text is freely available (open access, CC BY 4.0). Funded by: the Innovative Research Teams Project in Regular Higher Education Institutions of Guangdong Province, National Natural Science Foundation of China, Basic and Applied Basic Research Foundation of Guangdong Province.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Aminoglycoside antibiotics are essential in managing many life‐threatening diseases. However, their derivatives, such as neomycin, are associated with severe side effects such as persistent sensorineural hearing loss. Therefore, it is essential to elucidate the molecular and biochemical mechanisms of aminoglycoside‐induced ototoxicity and identify targets for alleviating ototoxic injury. Here, we provide a detailed cochlear cell atlas of neomycin‐induced acute and chronic ototoxicity‐related changes through single‐nucleus RNA sequencing profiling. Utilising this cochlear cell atlas, we used the Augur and scDist algorithms to evaluate cell‐type‐specific susceptibility to neomycin injury. We observed aberrant expression of X‐linked inhibitor of apoptosis (Xiap)–associated factor 1 (Xaf1) in neomycin‐exposed cochleae using the cochlear cell atlas, and we identified a novel role for Xaf1 in facilitating PANoptosis through overexpression and knockdown assays in vitro. Finally, we assessed the protective role of Xaf1 against neomycin‐induced ototoxicity by Xaf1 knockdown in cochlear hair cells using adeno‐associated virus‐based gene delivery. Mechanistically, Xaf1 orchestrates PANoptosis activation through direct interaction with and transcriptional regulation of ZBP1, establishing its hierarchical position upstream in the signalling cascade. This study presents detailed cochlear cellular maps of neomycin‐induced ototoxicity and serves as a valuable resource for identifying transcriptome‐wide disease‐driving perturbations at the single‐cell level. More importantly, we identified Xaf1 as a critical target for modulating the PANoptosis pathway, offering a promising treatment strategy for aminoglycoside‐induced ototoxicity.

Subjects

MeSH terms (MEDLINE)

AminoglycosidesTranscriptomeHearing LossAdaptor Proteins, Signal TransducingCell NucleusAnimalsMiceNeomycinHumansHair Cells, AuditoryAnti-Bacterial AgentsCochleaRNA-Binding Proteins

Author keywords

PANoptosisXaf1hair cellneomycinsnRNA‐seq

Substances

AminoglycosidesNeomycinAdaptor Proteins, Signal TransducingAnti-Bacterial AgentsRNA-Binding Proteins

Authors and institutions

  • Department of Otolaryngology Head and Neck Surgery, Zhongda Hospital, State Key Laboratory of Digital Medical Engineering, Jiangsu Provincial Key Laboratory of Critical Care Medicine, School of Life Sciences and Technol…
  • Southeast University Shenzhen Research Institute, Shenzhen, China.
  • School of Clinical and Basic Medical Sciences, Shandong Provincial Hospital, Medical Science and Technology Innovation Center, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, Shandong, C…
  • Department of Neurology, Aerospace Center Hospital, School of Life Science, Beijing Institute of Technology, Beijing, China.
  • Co-Innovation Center of Neuroregeneration, Nantong University, Nantong, China.
  • Institute for Stem Cell and Regeneration, Chinese Academy of Science, Beijing, China.

ORCID profiles: Renjie Chai, Shasha Zhang

Funding

  • the Innovative Research Teams Project in Regular Higher Education Institutions of Guangdong Province
  • National Natural Science Foundation of China
  • Basic and Applied Basic Research Foundation of Guangdong Province
  • National Key Research and Development Program of China
  • STI2030-Major Projects
  • China Ministry of Science and Technology Grant
  • Shenzhen Science and Technology Program
  • China Postdoctoral Science Foundation

Cite

APA

Wang, X., Xiao, H., Wu, J., Lin, Y., Ao, Y., Ye, Z., Tan, X., Kong, F., Chen, X., Chai, R., & Zhang, S. (2026). Single‐Nucleus Transcriptomics Uncovers Xaf1‐Driven PANoptosis as a Therapeutic Target in Aminoglycoside‐Induced Hearing Loss. Cell Proliferation. https://doi.org/10.1111/cpr.70081

Vancouver

Wang X, Xiao H, Wu J, Lin Y, Ao Y, Ye Z, et al. Single‐Nucleus Transcriptomics Uncovers Xaf1‐Driven PANoptosis as a Therapeutic Target in Aminoglycoside‐Induced Hearing Loss. Cell Proliferation. 2026. doi:10.1111/cpr.70081

BibTeX
@article{Wang2026,
  author = {Wang, Xinlin and Xiao, Hairong and Wu, Jiheng and Lin, Yanqin and Ao, Yiheng and Ye, Zixuan and Tan, Xin and Kong, Fanliang and Chen, Xin and Chai, Renjie and Zhang, Shasha},
  title = {Single‐Nucleus Transcriptomics Uncovers Xaf1‐Driven PANoptosis as a Therapeutic Target in Aminoglycoside‐Induced Hearing Loss},
  journal = {Cell Proliferation},
  year = {2026},
  doi = {10.1111/cpr.70081}
}
Start for free →